Brand Name(s): Airomir; Asthalin; Asmol;

Buventol; Proventil; Salamol; Sultanol; Ventolin;

Volmax
CAS nº: 18559-94-9
(sal BYOU tah mol)

About Salbutamol

This new site is dedicated exclusively to salbutamol, also known as albuterol.

It offers you the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.

Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about salbutamol on this reference site, as well as take part in our open discussion forum by sharing your own knowledge and experience with people who are using this medication.

This unique site also provides you with inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total salbutamol experience! 

Why is this medication prescribed?

Salbutamol (INN) or albuterol (USAN) is used to treat bronchospasms (wheezing, coughing and shortness of breath) associated with lung-related problems such as asthma, bronchitis, emphysema and other lung-related problems such as COPD (Chronic Obstructive Pulmonary Disease).

It works by relaxing the muscles and air passages in the lungs so that air can flow into them more freely and improve breathing.

This medicine is also useful for the prevention of exercise-induced bronchospasm, as well as indicated in hyperkalemia, especially in patients with renal failure.

Salbutamol is sold worldwide under several brand names, including Airomir®, Asthalin®, Asmol®, Buventol®, Proventil®, Salamol®, Sultanol®, Ventolin® and Volmax®.
 

See more Product Info

Latest News

Ractopamine discovered in imported pig kidneys

Imported frozen pig kidneys from Canada have recently been found to contain residue of ractopamine,...

[more]

CAS to rule on Petacchi doping case

The Court of Arbitration for Sport (CAS) will rule on Italian rider Alessandro Petacchi's positive...

[more]

Study critical of newer asthma inhaler favoured by Pharmac

A study says asthmatics have had more attacks and hospitalisations since the government stopped...

[more]

Datamonitor: Asthma/COPD combo products here to stay

London - Sufferers of respiratory diseases such as asthma and chronic obstructive pulmonary disease...

[more]

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.